论文部分内容阅读
药品集中招标采购这项制度的本身是为了发挥带量采购优势、实现量价挂钩、降低虚高药价的改革探索。但是安徽省蚌埠市的做法,表面看药品价格是降低了,但从长远看将对蚌埠人民群众的医疗卫生事业造成危害。首先,蚌埠市的这一做法虽然使得30个品种的药品价格降低,但却使更多无法满足25%降幅的优秀制药企业无奈放弃蚌埠市的公立医疗机构市场,这些优质企业的其他优秀产品(如优质廉价药、临床急需药、弥补临床需求空白的创新药等)也将无法被蚌埠市的公立
This system of bidding and purchasing of medicines in itself is to explore the reform in order to bring the advantages of quantity procurement, to realize the link between quantity and price, and to reduce the price of artificial drugs. However, the practice in Bengbu City of Anhui Province shows that the prices of medicines are reduced on the surface, but in the long run it will endanger the medical and health undertakings of the people in Bengbu. First of all, although Bengbu’s approach of lowering the prices of medicines of 30 varieties has enabled more excellent pharmaceutical enterprises that can not meet the 25% decline to abandon the market of public medical institutions in Bengbu, other excellent products from these high-quality enterprises Such as high-quality low-cost drugs, clinically urgent medicines, innovative medicines that make up for the blank of clinical needs, etc.) will not be able to be publicized by Bengbu